AzTrials
AzTrials

InfectionNCT03844776

Preoperative Dose of Co-amoxiclav for Prevention of Postoperative Complications in Dentoalveolar Surgery

A study testing Co-Amoxiclav, Paracetamol and Chlorhexidine mouthwash in people with Infection, run by Taibah University at 1 site in Saudi Arabia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

There was no evidence to judge the effects of preventative antibiotics for extractions of severely decayed teeth, teeth in diseased gums, or extractions in patients who are sick or have low immunity to infection. Undertaking research in these groups of people may not be possible or ethical. Read more about this study

Who is it for?
Ages 16 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Infection
What is being tested?
Co-Amoxiclav, Paracetamol and Chlorhexidine mouthwash
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
135 participants
Where
1 siteSaudi Arabia
Study dates
2 Oct 2019to 20 Jan 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Patient age from 16 to 70 yrs old
  • Patient needs surgical teeth extraction (subject tooth will be removed using osteotomy by motorised drill).

Who cannot join

  • Patients refusing the preoperative dose of oral co-amoxiclav, and unwilling to take part .
  • Patients who are allergic to co-amoxiclve, amoxicillin or metronidazole
  • Patient are on warfarin medication

Trial locations and contacts

1 site in 1 country.

Saudi Arabia1 site, 1 recruiting
  • Taibah University

    Madinah, 41311

    Giath Gazal, PhD

    Recruiting

Other trials in Saudi Arabia

About this study

Official title: A Comparison of Single Preoperative Dose of Co-amoxiclav Versus Postoperative Full Course of Amoxicillin/ Co-amoxiclav in Prevention of Postoperative Complications in Dentoalveolar Surgery: a Randomized Controlled Trial

There was no evidence to judge the effects of preventative antibiotics for extractions of severely decayed teeth, teeth in diseased gums, or extractions in patients who are sick or have low immunity to infection. Undertaking research in these groups of people may not be possible or ethical. However, it is likely that in situations where patients are at a higher risk of infection that preventative antibiotics may be beneficial, because infections in this group are likely to be more frequent and more difficult to treat To the best of knowledge, no adult study has compared the effects of single dose of Co-Amoxiclave and full oral course before or after dentoalveolar surgery. The current study has formally considered this comparison as a potential valuable trail for reducing the postoperative complications in adult patients who have had surgical removal of teeth under LA.

Read the detailed description

A comparison of single preoperative dose of Co-amoxiclav versus postoperative full course of Amoxicillin/ Co-amoxiclav in prevention of postoperative complications in dentoalveolar surgery: a randomized controlled trial

Background considerations Prophylactic antibiotics and corticoid in a single dose regimen did not bring any benefit on mandibular third molar surgeries.

Tooth extraction is a surgical treatment to remove teeth that are affected by decay or gum disease or impacted wisdom teeth or those causing pain or inflammation.

The risk of infection after extracting wisdom teeth from healthy young people is about 10%; however, it may be up to 25% in patients who are already sick or have low immunity. Infectious complications include swelling, pain, pus drainage, fever, and also dry socket. Treatment of these infections is generally simple and involves patients receiving antibiotics and drainage of infection from the wound.

A review study was carried out to investigate the effectiveness of Antibiotics to prevent complications following tooth extractions. The findings revealed that there is evidence that prophylactic antibiotics reduce the risk of infection, dry socket and pain following third molar extraction and result in an increase in mild and transient adverse effects. However, patients at a higher risk of infection are more likely to benefit from prophylactic antibiotics, because infections in this group are likely to be more frequent, associated with complications and be more difficult to treat.

Dry socket is a complication that occurs frequently after tooth extraction, causing discomfort to the patient, pain, and a fetid odor. Another study was carried out to investigatethe incidence and risk factors which played the main role in dry socket following surgical removal of impacted third molar in an Iranian population. The outcome of this study revealed that the incidence of dry socket was 19.14%. Age, gender, systemic disorder, and antibiotics use prior to surgery revealed no significant associations with dry socket. However, incidence of dry socket was significantly relevant to smoking, oral contraceptive use, menstruation cycle, difficulty of the surgery according to pre-surgery radiograph evaluation and perception of surgeon post-surgery, length of surgery, and number of carpules used to reach anesthesia. Tolstunov's study demonstrated that the post-extraction socket bleeding is very important for the proper uncomplicated socket healing. If the irrigation solution has not used at the end of extraction, the normal blood clot has a higher likelihood to form, and therefore, can potentially lead to an uncomplicated socket healing without development of alveolar osteitis. Socket bleeding at the extraction site creates a favorable environment for the formation of a blood clot - a protective dressing - necessary for a favorable osseous healing of the socket.

There was no evidence to judge the effects of preventative antibiotics for extractions of severely decayed teeth, teeth in diseased gums, or extractions in patients who are sick or have low immunity to infection. Undertaking research in these groups of people may not be possible or ethical. However, it is likely that in situations where patients are at a higher risk of infection that preventative antibiotics may be beneficial, because infections in this group are likely to be more frequent and more difficult to treat.

To the best of knowledge, no adult study has compared the effects of single dose of Co-Amoxiclave and full oral course before or after dentoalveolar surgery. The current study has formally considered this comparison as a potential valuable trail for reducing the postoperative complications in adult patients who have had surgical removal of teeth under LA.

Primary aim The aim of this study was to assess the efficacy of a single prophylactic dose of Co-Amoxiclave and full oral course in preventing postoperative complications (PC) after a surgical removal of upper and lower teeth.

Material and methods This randomized double-blind clinical trial included 50 patients diagnosed with dentoalveolar surgery. Patients received either preoperative single dose of 625mg Co-Amoxiclav and 1g paracetamol associated with 0.2% chlorhexidine mouthwash or postoperative full course of Co-Amoxiclav for 5 days with 0.9% normal saline irrigation or postoperative full course of amoxicillin 500 mg for five days with 0.9% normal saline irrigation. Patients were reviewed 5 days following the surgery and evaluated if they had alveolar infection, alveolar osteitis, trismus, edema and pain. Difficulty of surgery was reported by the surgeon by using (VAS).

Forty five patients who satisfy the inclusion criteria will be involved in the study and undergo surgical removal of their teeth. . Patients refusing the preoperative dose of oral co-amoxiclav, and unwilling to take part were excluded. Patients who are allergic either to co-amoxiclve or amoxicillin were also excluded. To be included in the study, the tooth must need surgery and require an osteotomy for extraction with use of a motorised drill. Patients will be divided in 3 groups according to the follow up protocol. Patients will be randomly allocated to one of three groups. Patients and assessor will not be aware of the exact treatment which will carry out.

  • Treatment 1: 0.9% normal saline irrigation immediately after the surgery with course of Co-Amoxiclav 625 mg 0.2% chlorhexidine mouthwash following the surgery for 5 days (control group)
  • Treatment 2: 625 mg Co-Amoxiclav and 1g Paracetamol preoperatively and 0.2% chlorhexidine mouthwash immediately before the surgery with course of Metronidazole 500 mg and 0.2% chlorhexidine mouthwash following the surgery for 5 days
  • Treatment 3: 625 mg Co-Amoxiclav and 1g Paracetamol preoperatively and 0.2% chlorhexidine mouthwash immediately before the surgery with course of amoxicillin 500 mg and 0.2% chlorhexidine mouthwash following the surgery for 5 days

All surgeries will be done under local anaesthesia. A standard extraction technique of surgery will be employed for the patient in first group. This include a buccal full-thickness flap, buccal trough (osteotomy) and extraction of the tooth), followed by a traditional end-of-surgery debridement protocol consisting of a gentle curettage, socket irrigation with approximately 5 ml of sterile normal saline solution , socket suctioning and placement of stitches.

  • Signs of alveolar osteitis may include:
  1. An empty socket, which is partially or totally devoid of blood clot.
  2. Exposed bone may be visible or the clot may be filled with food debris which reveals the exposed bone once it is removed. The exposed bone is extremely painful to touch.
  3. Surrounding inflamed soft tissues may overlie the socket and hide the dry socket from casual examination (Daly et al., 2012)
  • Symptomsof alveolar osteitis may include:
  1. Dull, aching, throbbing pain in the area of the socket, which is moderate to severe and may radiate to other parts of the head such as the ear, temple and neck. The pain normally starts on the second to fourth day after the extraction,[ and may last 10-40 days.The pain may be so strong that even strong analgesics do not relieve it.
  2. Intraoral halitosis
  3. Bad taste in the mouth (Fragiskos, 2007)
  • Signs and symptoms of oral infection
  1. Oral swelling
  2. Tenderness with touch
  3. Pus drainage
  4. Difficulty fully opening your mouth or swallowing. Power calculation A study with 45 subjects was reported to have 90% power to detect a difference in success rate of 21% (Bortoluzzi et al, 2013) in a continuous outcome measure assuming a significance level of 5% and a correlation of 0.5 between responses from the different subjects.
Conditions
Infection
Being tested
Co-Amoxiclav, Paracetamol, Chlorhexidine mouthwash, Normal saline, Amoxicillin 500 Mg
Keywords
dry socket, bleeding, swelling
Medical subject headings
Infections, Dry Socket, Hemorrhage

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Co-AmoxiclavDrug

    amoxicillin + clavulanic acid orally

  • ParacetamolDrug

    paracetamol orally

  • Chlorhexidine mouthwashDrug

    0.2% chlorhexidine mouthwash

  • Normal salineDrug

    0.9% normal saline irrigation

  • Amoxicillin 500 MgDrug

    Amoxicillin 500 orally

  • MetronidazoleDrug

    metronidazole 500 mg orally

Study groups in NCT03844776
Study groupRoleWhat they receive
Co-Amoxiclav postoperatively aloneActive comparator• Treatment 1: 0.9% normal saline irrigation immediately after the surgery with course of Co-Amoxiclav 625 mg 0.2% chlorhexidine mouthwash following the surgery for 5 days (control group)
Receives: Drug: Co-Amoxiclav; Drug: Chlorhexidine mouthwash; Drug: Normal saline
Co-Amoxiclav preoperatively with Metronidazole postoperativelyActive comparator• Treatment 2: 625 mg Co-Amoxiclav and 1g Paracetamol preoperatively and 0.2% chlorhexidine mouthwash immediately before the surgery with course of Metronidazole 500 mg and 0.2% chlorhexidine mouthwash following the surgery for 5 days
Receives: Drug: Co-Amoxiclav; Drug: Paracetamol; Drug: Chlorhexidine mouthwash; Drug: Normal saline; Drug: Metronidazole
Co-Amoxiclav preoperatively with amoxicillin postoperativelyActive comparator• Treatment 3: 625 mg Co-Amoxiclav and 1g Paracetamol preoperatively and 0.2% chlorhexidine mouthwash immediately before the surgery with course of amoxicillin 500 mg and 0.2% chlorhexidine mouthwash following the surgery for 5 days
Receives: Drug: Co-Amoxiclav; Drug: Paracetamol; Drug: Chlorhexidine mouthwash; Drug: Normal saline; Drug: Amoxicillin 500 Mg

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. infection rate

    dry socket after surgical extraction

    Measured: 5 days after extraction assessment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Feb 2019
  2. Study start2 Oct 2019
  3. Primary completion2 Dec 2020 (estimated)
  4. Study completion20 Jan 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Model description
* Treatment 1: 0.9% normal saline irrigation immediately after the surgery with course of Amoxicillin 500 mg following the surgery for 5 days (control group) * Treatment 2: 625 mg Co-Amoxiclav and 1g paracetamol preoperatively and 0.2% chlorhexidine mouthwash immediately before the surgery but there is no additional course of antibiotic following the surgery. * Treatment 3: 0.9% normal saline irrigation immediately after the surgery with course of antibiotic Co-Amoxiclav for five days postoperatively
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
135 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03844776
Sponsor's protocol ID
IORG0008371
Status last verified
Oct 2020
First submitted
11 Feb 2019
Last updated
6 Oct 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Co-Amoxiclav, Paracetamol and Chlorhexidine mouthwash in people with Infection, run by Taibah University at 1 site in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Giath Gazal (00966532158597, gazal73@yahoo.co.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

infection rate (time frame: 5 days after extraction assessment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in